Personalised antioxidant treatment for type 2 diabetes
The Australian Catholic University (ACU) are conducting a study about type 2 diabetes and nutrition.
Aim of the study:
This study is investigating the effects of personalised antioxidant supplementation on glycaemic control in people with type 2 diabetes. This trial is important as it may identify a simple and accessible nutritional intervention that can improve health outcomes in people with type 2 diabetes.
To take part in this study, you must:
- Be aged between 35 and 75 years
- Have a confirmed type 2 diabetes diagnosis
- Not be taking insulin
- Have an HbA1c ≥ 6.5%
Requirements:
Participation in this study involves 9 laboratory visits lasting between 30 minutes and 2 hours. During these visits, participants will undergo body composition scanning, blood sampling, and supervised exercise.
- ACU Melbourne Campus 115 Victoria Parade, Fitzroy and/or
- Baker Heart and Diabetes Institute 99 Commercial Rd, Melbourne
Please click here for further information and Participant Information Letter
This study has received Ethics approval from the ACU Human Research Ethics Committee (2024-3636HC).